Cargando…

Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates and evaluation of hospital-acquired infections

Background: Multidrug-resistant organisms (MDROs) are increasingly implicated in nosocomial outbreaks worldwide. We evaluated whole-genome sequencing (WGS) as an adjunctive epidemiological tool to identify infection clusters and MDRO transmission in the healthcare setting. Methods: Clinical isolates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ajaka, Leama, Day, Shandra, Liscynesky, Christina, Colburn, Nora, Sun, Christine, Sovic, Michael, Pancholi, Preeti, Balada-Llasat, Joan-Miquel, Smith, Heather, Murthy, Shashanka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Mdr Gnr
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594297/ http://dx.doi.org/10.1017/ash.2023.335

Ejemplares similares

Inpatient point-prevalence screening of New Delhi Metallo-β-lactamase (NDM)–producing Enterobacaterales and Candida auris
por: Greco, Christian, et al.
Publicado: (2022)

Carbapenemase genes and mortality in patients with carbapenem-resistant Enterobacterales, Atlanta, Georgia, 2011–2020
por: Witt, Lucy, et al.
Publicado: (2023)

Carbapenem-resistant Enterobacterales susceptibility patterns to new antimicrobials: A single-center analysis
por: Monk, Miranda, et al.
Publicado: (2023)

Identifying patients at high risk for carbapenem-resistant Enterobacterales carriage upon admission to acute-care hospitals
por: Howard-Anderson, Jessica, et al.
Publicado: (2023)

Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in hospitalized patients in Botswana
por: Mannathoko, Naledi Betsi, et al.
Publicado: (2023)

Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
por: Clark, Justin, et al.
Publicado: (2021)

Characterization of carbapenem-resistant gram-negative bacteria collected in the Sentinel Surveillance Program, 2018–2019
por: Spicer, Lori, et al.
Publicado: (2022)

How Does Antimicrobial Resistance Increase Medical Costs in Community-Acquired Acute Pyelonephritis?
por: Kim, Bongyoung, et al.
Publicado: (2021)

Time Above All Else: Pharmacodynamic Analysis of Β-Lactams in Critically Ill Patients
por: Landmesser, Katherine, et al.
Publicado: (2021)

Evaluation of Ceftolozane/Tazobactam, Ceftazidime/Avibactam and Meropenem/Vaborbactam Against Multidrug-Resistant (MDR) Pseudomonas
por: Shamsulddin, Haider, et al.
Publicado: (2021)

Treatment of Extensively Drug-Resistant (XDR) Acinetobacter in US Veterans’ Affairs (VA) Medical Centers
por: Fitzpatrick, Margaret, et al.
Publicado: (2021)

Stewardship Nightmare: Ceftolozane/Tazobactam–Resistant Pseudomonas aeruginosa Infections Accelerated by the COVID-19 Pandemic
por: Haviland, Adam, et al.
Publicado: (2021)

Management of Pseudomonas aeruginosa Bloodstream Infection and Impact on Health Outcomes
por: Ramanathan, Swetha, et al.
Publicado: (2021)

Pseudomonas aeruginosa bacteremia mortality and resistance trends in the Veterans’ Health Administration (VHA) system
por: Hojat, Leila, et al.
Publicado: (2022)

Low function and frequent readmission in nursing home patients with persistent resistant gram-negative bacterial colonization
por: Mills, John, et al.
Publicado: (2022)

A retrospective longitudinal observational study of natural history of ESBL/MDR gram negative organisms in patients hospitalized in a tertiary hospital
por: Vasudeva, Shikha, et al.
Publicado: (2022)

Characteristics of patients positive for COVID-19 and multidrug-resistant organisms in Tennessee, 2020–2021
por: Stover, Carolyn, et al.
Publicado: (2022)

Predicting the regional impact of interventions to prevent and contain multidrug-resistant organisms
por: Cincotta, Samuel, et al.
Publicado: (2022)

Real-world clinical outcomes of cefiderocol therapy in the Veterans Health Administration, 2019–2022
por: Amenta, Eva, et al.
Publicado: (2023)

2171. Clinical Characteristics and Outcomes of Immunocompromised Patients with Enterococcal Pneumonia
por: Ajaka, Leama, et al.
Publicado: (2022)

SG-APSIC1097: The impact of COVID-19 on the incidence of carbapenem-resistant Enterobacterales (CRE) in Singapore: An interrupted time-series analysis
por: Ong, Chong Hui Clara, et al.
Publicado: (2023)

SG-APSIC1159: Control of hospital-acquired carbapenemase-producing carbapenem-resistant Enterobacteriaceae colonization: A descriptive study
por: Wu, Tuodi, et al.
Publicado: (2023)

Evaluation of commercial ResPlex II v2.0, MultiCode(®)-PLx, and xTAG(®) respiratory viral panels for the diagnosis of respiratory viral infections in adults
por: Balada-Llasat, Joan-Miquel, et al.
Publicado: (2011)

COVID-Associated Pulmonary Aspergillosis in the United States: Is It Rare or Have We Missed the Diagnosis?
por: Zhang, Sean X., et al.
Publicado: (2021)

Zoster on the brain: Clinical characteristics of patients PCR positive for varicella-zoster virus in cerebrospinal fluid and implications for transmission base
por: Al-Saadi, Mahmoud, et al.
Publicado: (2022)

Experiential learning and mentorship as the foundation of clinical epidemiology training during infectious diseases fellowship: Response to “Training infectious diseases fellows for a new era of hospital epidemiology”
por: Day, Shandra R., et al.
Publicado: (2022)

Candidemia before and after the COVID-19 pandemic: An analysis of risk factors and outcomes in patients with candidemia
por: Colburn, Nora, et al.
Publicado: (2022)

A case of Wohlfahrtiimonas chitiniclastica bacteremia in continental United States
por: Chavez, Jesus A., et al.
Publicado: (2017)

SG-APSIC1157: The attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections—A prospective cohort study in Suva, Fiji
por: Loftus, Michael, et al.
Publicado: (2023)

Transmission of COVID-19 on an Inpatient Hospital Prison Unit
por: Witherspoon, Kelsey, et al.
Publicado: (2021)

Yersinia Has a Tropism for B and T Cell Zones of Lymph Nodes That Is Independent of the Type III Secretion System
por: Balada-Llasat, Joan-Miquel, et al.
Publicado: (2006)

Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
por: Ajaka, Leama, et al.
Publicado: (2020)

SG-APSIC1209: Risk factors associated with mortality among carbapenem-resistant Enterobacteriaceae inpatient in a tertiary-care teaching hospital in Malaysia
por: Sri Ponnampalavanar, Sasheela Sri La, et al.
Publicado: (2023)

SG-APSIC1203: Detection of carbapenemase genes in donor lungs at the point of care before transplantation reduces the risk of carbapenem-resistant Enterobacteriaceae–associated donor-derived infection in lung-transplant recipients
por: Zhou, Wenyong, et al.
Publicado: (2023)

367. Clinical Characteristics and Outcomes in Patients with Pneumonia secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Nichols, Courtney, et al.
Publicado: (2020)

A Cluster of Coronavirus Disease 2019 (COVID-19) Cases on an Inpatient Hospital Unit Involving Multiple Modes of Transmission
por: Witherspoon, Kelsey, et al.
Publicado: (2021)

Kerstersia gyiorum Isolated from a Bronchoalveolar Lavage in a Patient with a Chronic Tracheostomy
por: Deutscher, Meredith, et al.
Publicado: (2014)

Identification and significance of Weissella species infections
por: Kamboj, Kamal, et al.
Publicado: (2015)

Detection of toxigenic Clostridium difficile colonization in patients admitted to the hospital for chemotherapy or haematopoietic cell transplantation
por: Vaughn, John L., et al.
Publicado: (2018)

Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016–2018
por: Paveenkittiporn, Wantana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ubau5qer3sk7gkku95dqvii7ag